Global Vaccines Market

Product Code FRS01375
Publication Date December 2009
Publisher Frost & Sullivan
Product Type Report
Pages 84
ISBN Number not applicable

Global Vaccines Market

This research service covers the global vaccines market from 2005-2015. Included is discussion of issues such as key trends, products, challenges, drivers, and competitive structure. Revenue forecasts are also presented for the global market, North America, Europe, and Rest-of-World, with geographic and company market shares at the global level. Vaccines as a value of total revenues for key companies in the market are also assessed, Quarter-by-Quarter HPV vaccine growth rate trends by region, as well as weighting of vaccines revenues as a percent of regional revenues for the pharma industry. The pipeline for vaccines is also presented by clinical trial phase, as well as selected commentary for key disease areas.

Contents

1. Executive Summary
      Global Vaccines Market
          o Introduction

 2. Market Introduction
      Research Scope and Methodology
          o Scope and Segmentation
          o Research Methodology
      Market Overview
          o Introduction
          o Market Engineering Measurements
          o Industry Challenges
          o Market Drivers

 3. Market Analysis
      Competitive Analysis
          o Competitive Structure
      Market Share Analysis
          o Company Market Share
          o Geographic Market Share
      Revenue Forecasts
          o Global Market Overview
          o North American Market
          o European Market
          o Rest-of-World Market

 4. Pipeline Analysis
      Pipeline Analysis
          o Overview
          o Preregistration
          o Phase III
          o Phase II
          o Phase I
      Selected Disease Pipeline Commentary
          o Oncology
          o HIV
          o Diabetes
          o Endemic Diseases

 5. Appendix
      Decision Support Databases
          o Total Population
          o Total Healthcare Expenditure
          o Percentage of Infants Vaccinated with Hib Vaccine
          o Infant Population
          o Personal Disposable Income
          o Cervical Cancer Incidence